{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:55:31Z","timestamp":1777434931643,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"9641","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/s0140-6736(08)61170-8","type":"journal-article","created":{"date-parts":[[2008,8,30]],"date-time":"2008-08-30T04:56:13Z","timestamp":1220072173000},"page":"807-816","source":"Crossref","is-referenced-by-count":861,"title":["Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"372","clinical-trial-number":[{"clinical-trial-number":"nct00143507","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kim","family":"Fox","sequence":"first","affiliation":[]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[]},{"given":"P Gabriel","family":"Steg","sequence":"additional","affiliation":[]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(08)61170-8_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.38695.605440.AE","article-title":"Predicting prognosis in stable angina\u2014results from the Euro heart survey of stable angina: prospective observational study","volume":"332","author":"Daly","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(08)61170-8_bib2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)61170-8_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","article-title":"The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis","volume":"39","author":"Burns","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(08)61170-8_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(08)61170-8_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Resting heart rate in cardiovascular disease","volume":"50","author":"Fox","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(08)61170-8_bib7","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1081\/CEH-200031959","article-title":"Elevated heart rate: A major risk factor for cardiovascular disease","volume":"26","author":"Palatini","year":"2004","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/S0140-6736(08)61170-8_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease","volume":"26","author":"Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehn123","article-title":"Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR\/trandolapril STudy (INVEST)","volume":"29","author":"Kolloch","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib11","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","article-title":"Heart rate lowering by specific and selective If current inhibition with ivabradine. A new therapeutic perspective in cardiovascular disease","volume":"64","author":"DiFrancesco","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/S0140-6736(08)61170-8_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2125.2005.02544.x","article-title":"Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise","volume":"61","author":"Joannides","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S0140-6736(08)61170-8_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000073933","article-title":"A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction","volume":"100","author":"Manz","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/S0140-6736(08)61170-8_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00126839-200304020-00001","article-title":"Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology","volume":"4","author":"Camm","year":"2003","journal-title":"Drugs R D"},{"key":"10.1016\/S0140-6736(08)61170-8_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial","volume":"107","author":"Borer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(08)61170-8_bib16","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ahj.2006.01.013","volume":"152","author":"Fox","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000112412","article-title":"The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population","volume":"110","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/S0140-6736(08)61170-8_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(08)61170-8_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial","volume":"45","author":"McMurray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(08)61170-8_bib21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(08)61170-8_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"Peto","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(08)61170-8_bib23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(08)61170-8_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2013a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(08)61170-8_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijcard.2007.08.077","article-title":"Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms","volume":"126","author":"Giannoglou","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/S0140-6736(08)61170-8_bib26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/hc3801.096325","article-title":"Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption","volume":"104","author":"Heidland","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(08)61170-8_bib27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"Hjalmarson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(08)61170-8_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(05)74355-5","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"Dargie","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(08)61170-8_bib29","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673608611708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673608611708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T01:20:44Z","timestamp":1545787244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673608611708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":29,"journal-issue":{"issue":"9641","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0140673608611708"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(08)61170-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1122755.579832","asserted-by":"object"}]},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}